Interv Akut Kardiol. 2009;8(3):121-123
Introduction: Renal artery stenosis may result in an increase in blood pressure and the development of renal insufficiency; however, the
dilatation of stenosis using renal angioplasty has an indeterminate effect on the course of these conditions.
Objective: To assess the effect of percutaneous transluminal renal artery angioplasty (PTRA) on the course of hypertensive disease.
Methods: A retrospective study of the course of hypertensive disease in patients managed with PTRA at a single centre.
Results: In 26 patients, there was a significant decrease in the systolic (from 159 to 143 mm Hg, p = 0.02), diastolic (from 84 to 78 mm Hg,
p = 0.04) as well as mean blood pressures (from 108 to 100 mm Hg, p = 0.01), with a mean follow-up period of 8.6 months. The consumption
of antihypertensive drugs decreased significantly (from 3.56 to 2.38, p = 0.001). The group of patients with a favourable response to
PTRA (a decrease in the mean blood pressure by more than 10 mm Hg) was characterized by a significantly poorer initial management
of hypertension associated with an insignificantly higher number of antihypertensive drugs.
Conclusion: Angioplasty for atherosclerotic renal artery stenosis is beneficial in the management of hypertension, particularly in those
patients with poorly controlled hypertension and with a high consumption of antihypertensive drugs.
Published: July 15, 2009 Show citation